The 9th
International Conference on Alzheimer's
Disease Drug Discovery brought together
academic and industry scientists to
accelerate the development of novel drug
discovery programs for Alzheimer’s disease. Participants
included
academic and industry scientists engaged in
drug discovery research for
neurodegenerative diseases or CNS; business development and licensing
professionals; alliance management professionals;
venture capitalists and other
investors.>>>
This ADDF meeting is
one of the few conferences that
focuses exclusively on the
development of
innovative drugs
targeting
Alzheimer's disease
and related
dementias.
AIM 
This ADDF meeting is
one of the few conferences that
focuses exclusively on the
development of
innovative drugs
targeting
Alzheimer's disease
and related
dementias.
